Anti-inflammatory effects of a triterpenoid isolated from Wilbrandia ebracteata Cogn.

Life Sciences

Volumn 80, Issue 15, 2007, Pages 1382-1387

  Siqueira Jr , Jarbas Mota ^a   Peters, Rodrigo Rebelo ^b   Gazola, Andressa Córneo ^a   Krepsky, Patrícia Baier ^a   Farias, Mareni Rocha ^a   Rae, Giles Alexander ^a   de Brum Fernandes, Artur José ^c   Ribeiro do Valle, Rosa Maria ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

COX 2; Cucurbitaceae; Dihydrocucurbitacin B; LTB4; Mice; Paw edema; Pleurisy; Wilbrandia ebracteata

Indexed keywords

CARRAGEENAN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIHYDROCUCURBITACIN B; INTERLEUKIN 1ALPHA; LEUKOTRIENE B4; PROSTAGLANDIN E2; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN 3T3; CELL STRAIN COS7; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; EXPERIMENTAL STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; MALE; MEDICINAL PLANT; MOUSE; NEUTROPHIL; NONHUMAN; PAW EDEMA; PLANT ROOT; PLEURA CAVITY; PLEURA FLUID; PLEURISY; PROSTAGLANDIN RELEASE; WILBRANDIA EBRACTEATA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CERCOPITHECUS AETHIOPS; COS CELLS; CUCURBITACEAE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EDEMA; HUMANS; LEUKOTRIENE B4; MALE; METHYLENE CHLORIDE; MICE; NEUTROPHILS; NIH 3T3 CELLS; PLANT ROOTS; PLEURISY; SOLVENTS; TRITERPENES;

CUCURBITACEAE; MUS; WILBRANDIA EBRACTEATA;

EID: 33847619674     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.12.021     Document Type: Article

References (33)

1. Almeida F.R.C., Rao V.S.N., and Matos M.E.O. Anti-inflammatory, antitumour and antifertility effects in rodents of two nor-cucurbitacin glucosides from Wilbrandia species. Phytotherapy Research 6 (1991) 189-193
2. Bazzoni F., Cassatella M.A., Laudanna C., and Rossi F. Phagocytosis of opsonized yeast induces tumor necrosis factor-mRNA accumulation and protein release by human polymorphonuclear leukocytes. Journal of Leukocyte Biology 50 3 (1991) 223-228
3. Bennett A., Civier A., Hensby C.N., Melhuish P.B., and Stamford I.F. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut 28 3 (1987) 315-318
4. Borgeat P., Hamberg M., and Samuelsson B. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. Journal of Biological Chemistry 251 24 (1976) 7816-7820
5. Brito F.D. In: Liss A.A.R. (Ed). Pharmacological Methods in the Control of Inflammation (1989), Rhone Poulene LTD, Degenham 173-228
6. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. FASEB Journal 12 12 (1998) 1063-1073
7. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and Dubois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and carcinomas. Gastroenterology 107 (1994) 1183-1188
8. Farias M.R., and Schenkel E.P. Caracterização de cucurbitacinas em espécies vegetais conhecidas como taiuiá. Ciência e Cultura 39 (1987) 970-973
9. Farias M.R., Schenkel E.P., Mayer R., and Rücker G. Cucurbitacins as constituents of Wilbrandia ebracteata. Planta Medica 59 (1993) 272-275
10. FitzGerald G., and Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. New England Journal of Medicine 345 (2001) 433-442
11. Fries S., and Grosser T. The cardiovascular pharmacology of COX-2 inhibition. Hematology 1 (2005) 445-451
12. Funk C.D., Hoshiko S., Matsumoto T., Radmark O., and Samuelsson B. Characterization of the human 5-lipoxygenase gene. Proceedings of the National Academy of Sciences of the United States of America 86 (1989) 2587-2591
13. 2 formation in rat carrageenin-induced pleurisy. Prostaglandins 51 1 (1996) 19-33
14. Henriques M.G., Silva P.M., Martins M.A., Flores C.A., Cunha F.Q., Assreuy-Filho J., and Cordeiro R.S. Mouse paw edema. A new model for inflammation?. Brazilian Journal of Medical and Biological Research 20 2 (1987) 243-249
15. Henriques M.G., Rae G.A., Cordeiro R.S., and Williams T.J. Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse. British Journal of Pharmacology 106 3 (1992) 579-582
16. Lora M., Morisset S., Menard H.A., Leduc R., and de Brum-Fernandes A.J. Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin. Prostaglandins, Leukotrienes and Essential Fatty Acids 56 5 (1997) 361-367
17. Miró M. Cucurbitacins and their pharmacological effects. Phytotherapy Research 9 (1995) 159-168
18. Peters R.R., Farias M.R., and Ribeiro-do-Valle R.M. Anti-inflammatory and analgesic effects of cucurbitacins from Wilbrandia ebracteata Cogn. Planta Medica 63 (1997) 525-528
19. Peters R.R., Saleh T.F., Lora M., Patry C., de Brum-Fernandes A.J., Farias M.R., and Ribeiro-do-Valle R.M. Anti-inflammatory effects of the products from Wilbrandia ebracteata on carrageenan-induced pleurisy in mice. Life Sciences 26 (1999) 2429-2437
20. Peters R.R., Krepsky P.B., Siqueira-Junior J.M., Rocha J.C.S., Bezerra M.M., Ribeiro R.A., de Brum-Fernandes A.J., Farias M.R., Rocha F.A.C., and Ribeiro-do-Valle R.M. Nitric oxide and cyclooxygenase may participate in the analgesic and anti-inflammatory effect of the cucurbitacins fraction from Wilbrandia ebracteata. Life Sciences 73 17 (2003) 2185-2197
21. Qiao L., Kozoni V., Tsioulias G.J., Koutsos M.I., Hanif R., Shiff S.J., and Rigas B. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochimica et Biophysica Acta 1258 2 (1995) 215-223
22. Rigas B., Goldman I.S., and Levine L. Altered eicosanoid levels in human colon cancer. Journal of Laboratory and Clinical Medicine 22 (1993) 518-523
23. Safayhi H., and Sailer E.R. Anti-inflammatory actions of pentacyclic triterpenes. Planta Medica 63 (1997) 487-493
24. Salviano P.A. Revisão sobre o uso terapêutico da Luffa operculata (L) Cogniaux (cabacinha). Revista Brasileira de Medicina 49 9 (1992) 672-674
25. Salviano P.A. Tratamento da sinusite com preparação contendo Luffa operculata e solução fisiológica. Revista Brasileira de Medicina 49 9 (1992) 681-682
26. Santos R.I., Dos Santos M.A., and Schenkel E.P. Analysis of the plant drug Wilbrandia ebracteata Cogn. International Journal of Pharmacognosy 34 4 (1996) 300-302
27. Schenkel E.P., Farias M.R., Mayer R., Breitmaier E., and Rücker G. Cucurbitacins from Wilbrandia ebracteata. Phytochemistry 31 (1992) 1329-1333
28. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., and Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase-2 in inflammation and pain. Proceedings of the National Academy of Sciences of the United States of America 91 25 (1994) 12013-12017
29. Sheng H.M., Shao J.Y., Morrow J.D., Beauchamp R.D., and Dubois R.N. Modulation of apoptosis and bcl-2 expression by prostaglandin E-2 in human colon cancer cells. Cancer Research 58 2 (1998) 362-366
30. Simmons D.L., Botting R.M., and Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacological Reviews 56 3 (2004) 387-437
31. Turini M.E., and DuBois R.N. Cyclooxygenase-2: a therapeutic target. Annual Review of Medicine 53 (2002) 35-57
32. Vane J.R., and Botting R.M. Anti-inflammatory drugs and their mechanism of action. Inflammation Research 47 2 (1998) S78-S87
33. Zhang Y., Dewitt D.L., Murugesan S., and Nair M.G. Cyclooxygenase-2 enzyme inhibitory triterpenoids from Picrorhiza kurroa seeds. Life Sciences 77 25 (2005) 3222-3230